Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.075 USD | +0.12% | -3.33% | +53.58% |
May. 08 | Design Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 07 | Piper Sandler Upgrades Design Therapeutics to Overweight From Neutral | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+53.58% | 230M | |
+45.46% | 56.65B | |
-6.46% | 39.44B | |
+39.19% | 39.03B | |
-6.65% | 26.86B | |
+12.01% | 26.75B | |
-21.67% | 19.03B | |
+0.27% | 12.28B | |
+23.86% | 12.26B | |
+28.01% | 12.04B |
- Stock Market
- Equities
- DSGN Stock
- News Design Therapeutics, Inc.
- SVB Downgrades Design Therapeutics to Market Perform From Outperform, Cuts Price Target to $6 From $22